ChenGuang Biotech Group Co., Ltd. (SHE:300138)
China
· Delayed Price · Currency is CNY 14.30
-0.20 (-1.38%)
Mar 10, 2026, 10:45 AM CST
ChenGuang Biotech Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 94.05 | 479.72 | 434.03 | 351.51 | Upgrade
|
| Depreciation & Amortization | - | 166.5 | 152.83 | 144.85 | 130.74 | Upgrade
|
| Other Amortization | - | 0.65 | 0.2 | 0.9 | 0.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -4.89 | 0.63 | -1.08 | -0.1 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.46 | 1.1 | 1.32 | 10.91 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -12.68 | -74.02 | -33.45 | -30.93 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.11 | 0.87 | 0.77 | -1.93 | Upgrade
|
| Other Operating Activities | - | 197.19 | 80.74 | 100.25 | 74.9 | Upgrade
|
| Change in Accounts Receivable | - | 62.07 | 135.24 | -274.17 | -119.09 | Upgrade
|
| Change in Inventory | - | -670.57 | -1,145 | 187.13 | -435.93 | Upgrade
|
| Change in Accounts Payable | - | -41.67 | -211.8 | 176.31 | 90 | Upgrade
|
| Operating Cash Flow | - | -222.81 | -588.47 | 734.81 | 63.9 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 1049.93% | -87.93% | Upgrade
|
| Capital Expenditures | - | -149.54 | -189.2 | -176.03 | -280.82 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.02 | 0.28 | 0.42 | 3.58 | Upgrade
|
| Investment in Securities | - | -315.58 | -336.91 | -540.91 | - | Upgrade
|
| Other Investing Activities | - | 24.15 | 77.56 | 20.12 | 12.47 | Upgrade
|
| Investing Cash Flow | - | -440.95 | -448.27 | -696.4 | -264.76 | Upgrade
|
| Long-Term Debt Issued | - | 5,783 | 4,678 | 3,511 | 2,081 | Upgrade
|
| Total Debt Issued | - | 5,783 | 4,678 | 3,511 | 2,081 | Upgrade
|
| Long-Term Debt Repaid | - | -5,088 | -3,381 | -3,132 | -1,278 | Upgrade
|
| Total Debt Repaid | - | -5,088 | -3,381 | -3,132 | -1,278 | Upgrade
|
| Net Debt Issued (Repaid) | - | 695.8 | 1,297 | 378.58 | 803.12 | Upgrade
|
| Repurchase of Common Stock | - | -396.53 | -95.84 | - | - | Upgrade
|
| Common Dividends Paid | - | -174.05 | -181.41 | -143.98 | -109.77 | Upgrade
|
| Other Financing Activities | - | -21.41 | 276.95 | -195.55 | -152.39 | Upgrade
|
| Financing Cash Flow | - | 103.8 | 1,297 | 39.05 | 540.96 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -10.49 | -6.05 | -4.94 | -4.36 | Upgrade
|
| Net Cash Flow | - | -570.46 | 254.03 | 72.51 | 335.75 | Upgrade
|
| Free Cash Flow | - | -372.35 | -777.67 | 558.78 | -216.92 | Upgrade
|
| Free Cash Flow Margin | - | -5.32% | -11.32% | 8.88% | -4.45% | Upgrade
|
| Free Cash Flow Per Share | - | -0.72 | -1.46 | 1.05 | -0.41 | Upgrade
|
| Cash Income Tax Paid | - | 7.26 | 9.45 | -46.55 | -31.36 | Upgrade
|
| Levered Free Cash Flow | - | 39.79 | -997.32 | -131.42 | -423.74 | Upgrade
|
| Unlevered Free Cash Flow | - | 111.3 | -945.13 | -89.42 | -390.52 | Upgrade
|
| Change in Working Capital | - | -664.21 | -1,231 | 87.21 | -471.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.